Abstract
The discovery that an oxygen-induced protease inhibitor favours fibrin deposition in the lungs could lead to new ways to avoid oxygen toxicity. A new study (J Clin Invest 1996; 98: 2666–73), provides the first direct evidence for a causal link between decreased plasminogen activator (PA) activity and development of hyaline-membrane disease.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
